Continuous-Release Anti-VEGF Device for AMD Wins FDA Approval

(MedPage Today) -- The FDA has approved a first-of-its kind continuous delivery system for anti-VEGF therapy for neovascular (wet) age-related macular degeneration (AMD).
The Susvimo ocular implant continuously releases 100 mg/mL of ranibizumab...